SEC Form 4 · accession 0001209191-16-148146
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hung Do
Officer — Chief Science Officer
Period of report
Nov 1, 2016
Accepted (ET)
Nov 3, 2016 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2016 | S | 25,000 | $7.00 | D | 533,453 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016.